FTC clears Stryker/Wright Medical as Chopra questions adequacy of compliance monitoring

The Federal Trade Commission has conditionally approved Stryker’s $4 billion purchase of medical device rival Wright Medical, with Commissioner Rohit Chopra urging the agency to adjust how it monitors companies’ compliance with ordered remedies.

Unlock unlimited access to all Global Competition Review content